Cristina Esquinas

Universitat de Barcelona — Spain

Medicine · Health Sciences

36h-index4.5kcitations234works1.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Obstructive Pulmonary Disease (COPD) Research(63), Protease and Inhibitor Mechanisms(41), Respiratory Support and Mechanisms(26), Peptidase Inhibition and Analysis(26), Obstructive Sleep Apnea Research(25)

Publications232 total

Routine Blood Biomarkers in Patients With the PI*SZ Genotype of Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry
Archivos de Bronconeumología·2026
Routine Blood Biomarkers and Lung Disease in Patients with Alpha-1 Antitrypsin Deficiency from the EARCO Registry
Respiration·2025· 2 cited
External validation of the Uromonitor®‐version 2 urine test as a biomarker for optimisation of non‐muscle‐invasive bladder cancer management
British Journal of Urology·2025· 4 cited
Erectile dysfunction and testosterone deficiency in COPD: associations with disease severity and symptoms
2025
Characteristics of bronchiectasis in patients with different genotypes of severe α <sub>1</sub> -antitrypsin deficiency from the EARCO registry
ERJ Open Research·2025· 1 citedOpen Access
Quantification of serum elastase inhibitory activity in patients with pulmonary emphysema with and without alpha-1 antitrypsin deficiency
PLoS ONE·2025· 3 citedOpen Access
Lung disease in never-smokers with severe α <sub>1</sub> -antitrypsin deficiency: the EARCO Registry
ERJ Open Research·2025Open Access
Tolerance and effectiveness of inhaled antibiotics at standard or low doses in COPD patients with chronic Pseudomonas aeruginosa bronchial infection
Scientific Reports·2025· 3 citedOpen Access
A0675 – External validation of Uromonitor® as a biomarker for optimization of NMIBC follow up by the CUETO group; evaluation-CUETO study
European Urology·2025
Demographic and Clinical Characteristics of Mild, Young and Early COPD: A Cross-Sectional Analysis of 5468 Patients
Journal of Clinical Medicine·2024· 1 citedOpen Access
The Midline Catheter Within the Context of Home Intravenous Antibiotic Treatment
Journal of Infusion Nursing·2024· 1 citedOpen Access
Comparison of the Determinants of the “Chronic Obstructive Pulmonary Disease Assessment Test” (CAT) and the “Asthma Control Test” (ACT) in Patients with Asthma–COPD Overlap
Journal of Clinical Medicine·2024Open Access
Lung disease in never smokers with severe alpha1-antitrypsin deficiency: The EARCO Registry.
2024
Association between routine blood biomarkers, lung phenotypes and disease severity in patients with alpha-1 antitrypsin Pi*SZ deficiency from the EARCO Registry
2024
Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin: an EARCO research project
Respiratory Research·2024· 8 citedOpen Access
Blood biomarkers in patients with Alpha-1 Antitrypsin Deficiency from the EARCO CRC Registry
2023
Alpha-1 antitrypsin Pi*SS genotype and risk of pulmonary disease. An EARCO Research project
2023
Enhanced liver fibrosis (ELF) test as a biomarker of pulmonary fibrosis (PF) secondary to COVID-19 pneumonia.
2023
Impact of COVID-19 on patients with PiZZ alpha1-antitrypsin deficiency: the IMCA1 study revisited.
2023
Elastase inhibitory activity (EIA) in Chronic Obstructive Pulmonary Disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD)
2023
page 1 of 12Next →

Frequent Co-authors

Marc Miravitlles(25), Míriam Barrecheguren(11), Antònia Barceló(9), Ferrán Barbé(9), Manuel Sánchez‐de‐la‐Torre(7), Javier Piérola(6), Mónica de la Peña(6), Antoni Torres(5), Beatriz Lara(5), J.C. Angulo(5), Eva Polverino(4), Francisco Casas Maldonado(4), José M. Marı́n(4), Eduard Monsó(4), Esther Rodríguez(4), Catia Cillóniz(3), María Ángeles Marcos(3), José Mensa(3), Rosario Menéndez(3), R Martinez(3)